3
Announcements
Trials
Browse
Landscape
Status
Completed
7
Recruiting
5
Active not recruiting
5
Terminated
4
Withdrawn
2
No longer available
1
Sponsor Class
OTHER
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Amifampridine
4
fludarabine phosphate
3
gallium 68 PSMA-11
2
fludarabine
2
carbon-11 acetate
2
Whole-Body Irradiation
2
Magnetic Resonance Spectroscopy
2
Ga(III)-DOTATOC
2
Cyclophosphamide
2
3-Iodobenzylguanidine
2
venetoclax
1
veliparib
1
ulocuplumab
1
trametinib
1
selinexor
1
ponatinib
1
pembrolizumab
1
pegfilgrastim
1
omburtamab I-131
1
nirogacestat
1
neratinib
1
navitoclax
1
ganitumab
1
gallium Ga 68 dotatate
1
fluorodopa F 18
1
elotuzumab
1
carfilzomib
1
asparaginase erwinia chrysanthemi recombinant
1
aldesleukin
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
OTHER
×
asparaginase erwinia chrysanthemi recombinant
×
Clear all
NCT00590915
2026-01-23
EMTP
Phoenix Children's Hospital
No longer available